glp-1 drug New Guidelines on Drugs for Obesity Released GLP-1 Medications for Weight Loss:

For antidepressants like SSRIs, absorption may be delayed, but dose adjustments are rarely needed

Given their antiinflammatory properties, there has been some speculation that GLP-1 medicines could impair host immune defenses, but current clinical evidence does not indicate an increased risk of infections or obesity-related cancer (94)

[17] In people with high cardiovascular risk, liraglutide has been shown to reduce the risk for first occurrence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke

Pasternak B et al

Signs and symptoms may vary depending on the anatomical location